Expedia Group Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Buy

78

EXPE
Expedia Group

Last Price:

$180.23

Seasonality Move:

2.02%

Sell

8

CRNX
Crinetics Pharmaceuticals

Last Price:

$40.59

Seasonality Move:

-9.08%

Buy

78

Expedia Group (EXPE) is a Buy

Is Expedia Group a Buy, Sell or Hold?

The current Expedia Group [EXPE] share price is $182.62. The Score for EXPE is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
EXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

8

Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

EXPE Stock Price Chart

What is Expedia Group's stock price today?

The Expedia Group share price today is $182.62

The current trend is moderately bearish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

The Crinetics Pharmaceuticals share price today is $48.50

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

EXPE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.97	Buy
Relative Strength Index (14 RSI):	47.78	Sell
Chaikin Money Flow:	541365	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(181.94 - 189.42)	Sell
Bollinger Bands (100):	(141.93 - 182.79)	Buy

CRNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.69	Sell
Relative Strength Index (14 RSI):	34.32	Sell
Chaikin Money Flow:	-235099	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(51.1 - 56.94)	Sell
Bollinger Bands (100):	(51.5 - 57.46)	Sell

EXPE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	185.04	Sell
20-day SMA:	184.94	Sell
50-day SMA:	180.57	Buy
200-day SMA:	143.74	Buy
8-day EMA:	184.53	Sell
20-day EMA:	184.6	Sell
50-day EMA:	178.32	Buy
200-day EMA:	152.33	Buy

CRNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	50.85	Sell
20-day SMA:	53.18	Sell
50-day SMA:	55.63	Sell
200-day SMA:	51.03	Sell
8-day EMA:	50.82	Sell
20-day EMA:	52.67	Sell
50-day EMA:	54.22	Sell
200-day EMA:	49.96	Sell

Expedia Group Earnings Growth & EXPE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.26 per share, and an increase next year of $2.85 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Expedia Group Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):